Literature DB >> 28169208

Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center.

Miao-Erh Chang1, Hao-Jan Lei2, Ming-Huang Chen1, Yi-Chen Yeh3, Chung-Pin Li4, Yi-Ping Hung1, Cheng-Yuan Hsia5, Chieu-An Liu6, Gar-Yang Chau5, Yee Chao1.   

Abstract

BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver malignancy, and surgical resection remains the only potentially curative treatment. However, the existing literature indicates that those prognostic factors associated with outcome after surgery remain poorly defined.
METHODS: Data were retrospectively collected from 103 patients with ICC who underwent surgical resection between 2005 and 2014. The patients were divided into two groups: one with (D1) and one without (D0) lymph node dissection of hepatic hilum according to the surgery performed. Thereafter, the prognostic values of clinicopathological characteristics were evaluated.
RESULTS: The median overall survival (OS) after surgical resection of ICC was 43.9 months [95% confidence interval (CI), 11.6-76.2 months]. The 1-, 3-, and 5-year OS rates were 85.5%, 52.8%, and 45.6%, respectively. Multivariable analysis showed that lymph node metastases [hazard ratio (HR), 6.70; 95% CI, 2.18-20.55], positive resection margins (HR, 2.67; 95% CI, 1.14-6.23), periductal infiltration (HR, 3.64; 95% CI, 1.27-10.44), and poor differentiation (HR, 2.90; 95% CI, 1.41-5.95) were independently associated with poor survival. There were no significant differences in clinicopathological characteristics between D1 and D0 groups, except for vascular invasion (p = 0.018) and perineural invasion (p = 0.008). In the D1 group, lymph node metastases were associated with late T stages, multiple tumors, and elevated serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) levels.
CONCLUSION: Regional lymph node metastasis, positive resection margin, periductal infiltration, and poor differentiation were poor prognostic factors in patients with ICC after curative surgery. Lymph node dissection did not show survival benefits, but was useful for nodal staging. However, lymph node metastases were strongly associated with late T stages, multiple tumors, and elevated serum CEA and CA19-9 levels.
Copyright © 2017. Published by Elsevier Taiwan LLC.

Entities:  

Keywords:  cholangiocarcinoma; lymph node dissection; prognostic factors

Mesh:

Year:  2017        PMID: 28169208     DOI: 10.1016/j.jcma.2016.09.010

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  3 in total

1.  Postoperative adjuvant transarterial chemoembolization for intrahepatic cholangiocarcinoma patients with microvascular invasion: a propensity score analysis.

Authors:  Zhangjun Cheng; Zhengqing Lei; Xiaoling Jin; Qi Zhang; Anfeng Si; Pinghua Yang; Jiahua Zhou; Daniel Hartmann; Norbert Hüser; Feng Shen
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 2.  Effect of lymph node resection on prognosis of resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis.

Authors:  Feiyu Li; Yong Jiang; Liyong Jiang; Qingbin Li; Xiangyu Yan; Songhan Huang; Ji Chen; Shuai Yuan; Yingda Fu; Jun Liu
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738

3.  Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection.

Authors:  Jie Hu; Fei-Yu Chen; Kai-Qian Zhou; Cheng Zhou; Ya Cao; Hui-Chuan Sun; Jia Fan; Jian Zhou; Zheng Wang
Journal:  Oncotarget       Date:  2017-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.